1 Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333
2 Indian Health Service, HQW, Albuquerque, NM 87110
3 North Dakota State Department of Health and Consolidated Laboratories, Bismarck, ND 58505
4 Epidemiology Program, Aberdeen Area Indian Health Service, Rapid City, SD 57702
5 Environmental Health, Devils Lake Sioux Tribe, Fort Totten, ND 58335
Hantavirus pulmonary syndrome (HPS) is a recently recognized viral zoonosis characterized by a febrile prodrome progressing to severe noncardiogenic pulmonary edema.1-4 This syndrome is caused by at least three newly described hantaviruses: the first, Sin Nombre virus, is the Southwestern hantavirus that caused an outbreak of respiratory failure during the summer of 1993; the second, Black Creek Canal virus, caused a case of HPS in Florida; and the third hantavirus was identified in lung tissue from a patient in Louisiana. Diagnosis is by enzyme-linked immunosorbent assay (ELISA) serology with elevated immunoglobulin M (IgM) titers against heterologous and homologous hantaviral antigens, positive immunohistochemistry on formalin-fixed tissue, or reverse transcriptase-polymerase chain reaction (RT-PCR) amplification of hantaviral nucleotide sequence from frozen tissue.
Submitted on May 9, 1994
This article has been cited by other articles:
![]() |
M. M. Ramos, G. D. Overturf, M. R. Crowley, R. B. Rosenberg, and B. Hjelle Infection With Sin Nombre Hantavirus: Clinical Presentation and Outcome in Children and Adolescents Pediatrics, August 1, 2001; 108 (2): e27 - e27. [Abstract] [Full Text] [PDF] |
||||